Citations: The Pros and Cons of the In-silico Pharmaco-toxicology in Drug Discovery and Development

Soodabeh Saeidnia, Mohammad Abdollahi 2014. Perspective Studies on Novel Anticancer Drugs from Natural Origin:A Comprehensive Review Int. J. Pharmacol., 10: 90-108.
CrossRef |

Citations in impact factor journal as recorded by

Natural activators of adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities

Food and Chemical Toxicology

The importance of translatability in drug discovery

Expert Opinion on Drug Discovery Vol. 12, Issue 3, 237, 2017

Citation to this article as recorded by

Poisonous Plants and Phytochemicals in Drug Discovery

Cancer models in preclinical research: A chronicle review of advancement in effective cancer research

Animal Models and Experimental Medicine Vol. 4, Issue 2, 87, 2021

A Recurrent Neural Network model to predict blood–brain barrier permeability

Computational Biology and Chemistry

Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies

Scientific Reports Vol. 9, Issue 1, , 2019

Toxicity of nanomaterials; an undermined issue

DARU Journal of Pharmaceutical Sciences Vol. 22, Issue 1, , 2014

Identifying and Prioritizing Chemicals with Uncertain Burden of Exposure: Opportunities for Biomonitoring and Health-Related Research

Environmental Health Perspectives Vol. 127, Issue 12, 126001, 2019

Citations for "The Pros and Cons of the In-silico Pharmaco-toxicology in Drug Discovery and Development"

Citation to this article as recorded by

Citations in impact factor journal as recorded by

Citation to this article as recorded by